Cargando…
EWS-FLI1 and RNA helicase A interaction inhibitor YK-4-279 inhibits growth of neuroblastoma
Treatment failure in high risk neuroblastoma (NB) is largely due to the development of chemotherapy resistance. We analyzed the gene expression changes associated with exposure to chemotherapy in six high risk NB tumors with the aid of the Connectivity Map bioinformatics platform. Ten therapeutic ag...
Autores principales: | Sun, Wenjing, Rojas, Yesenia, Wang, Hao, Yu, Yang, Wang, Yongfeng, Chen, Zhenghu, Rajapakshe, Kimal, Xu, Xin, Huang, Wei, Agarwal, Saurabh, Patel, Roma H., Woodfield, Sarah, Zhao, Yanling, Jin, Jingling, Zhang, Hong, Major, Angela, Hicks, M. John, Shohet, Jason M., Vasudevan, Sanjeev A., Coarfa, Cristian, Yang, Jianhua, Nuchtern, Jed G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706912/ https://www.ncbi.nlm.nih.gov/pubmed/29212266 http://dx.doi.org/10.18632/oncotarget.21933 |
Ejemplares similares
-
Single Enantiomer of YK-4-279 Demonstrates Specificity in Targeting the Oncogene EWS-FLI1
por: Barber-Rotenberg, Julie S., et al.
Publicado: (2012) -
YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model
por: Minas, Tsion Zewdu, et al.
Publicado: (2015) -
The Effects and Mechanism of YK-4-279 in Combination with Docetaxel on Prostate Cancer
por: Yu, Lin, et al.
Publicado: (2017) -
YK-4-279 Inhibits ERG and ETV1 Mediated Prostate Cancer Cell Invasion
por: Rahim, Said, et al.
Publicado: (2011) -
The ETS Inhibitor YK-4-279 Suppresses Thyroid Cancer Progression Independent of TERT Promoter Mutations
por: Xue, Junyu, et al.
Publicado: (2021)